Diisopropylethylamine → N-[(3R)-1-Azabicyclo[2.2.2]oct-3-yl]thieno[3,2-b]pyridine-2-carboxamide

HRID 15451노트

반응식

HRID 15451 반응식
[S:1]1[C:9]2[C:4](=[N:5][CH:6]=[CH:7][CH:8]=2)[CH:3]=[C:2]1[C:10]([OH:12])=O.CN(C(ON1N=[N:28][C:23]2[CH:24]=[CH:25][CH:26]=[N:27][C:22]1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.[CH:37](N(CC)C(C)C)(C)[CH3:38]>CN(C=O)C>[N:27]12[CH2:26][CH2:25][CH:24]([CH2:37][CH2:38]1)[C@@H:23]([NH:28][C:10]([C:2]1[S:1][C:9]3[C:4](=[N:5][CH:6]=[CH:7][CH:8]=3)[CH:3]=1)=[O:12])[CH2:22]2

참가 물질

5

실험 절차

35 mg (0.20 mmol) of thieno[3,2-b]pyridine-2-carboxylic acid, 58.3 mg (0.29 mmol) of R-3-aminoquinuclidine dihydrochloride, 111.4 mg (0.29 mmol) of HATU, 138.8 mg (1.07 mmol) of N,N-diisopropylethylamine and 1.5 ml of DMF are reacted according to the general procedure (variant A). The reaction mixture is purified by preparative

후처리

  1. customThe reaction mixture is purified by preparative

출처 및 근거

ORD 기록
ord-78a133fbd75443e8852381f6c1278e8d
출처 데이터셋
uspto-grants-2010_06
특허 번호
US07732477B2

반응 노트

불러오는 중…